Sharp­less out­lines FDA’s key pri­or­i­ties for ad­vanc­ing pub­lic health

Four months in­to his tenure, Act­ing FDA Com­mis­sion­er Ned Sharp­less sent an email to FDA staff on Tues­day out­lin­ing four main pri­or­i­ty ar­eas: as­sur­ing pub­lic health through emerg­ing tech­nolo­gies, in­vest­ing in the FDA’s next gen­er­a­tion ex­pert work­force and in­fra­struc­ture, mod­ern­iz­ing frame­works and pro­mot­ing and pro­tect­ing con­sumer and pa­tient safe­ty.

On the emerg­ing tech­nolo­gies front, Sharp­less dis­cussed how the FDA is try­ing to stay ahead of the curve while en­cour­ag­ing in­dus­try to adopt less cost­ly and more re­li­able ad­vanced man­u­fac­tur­ing plat­forms.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER